Abemaciclib
Showing 26 - 50 of 198
Breast Cancer Trial in Shanghai (Chidamide, Abemaciclib, Fulvestrant)
Recruiting
- Breast Cancer
- Chidamide
- +2 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jul 31, 2022
Tumors Trial in Seoul (abemaciclib+paclitaxel)
Active, not recruiting
- Tumors
-
Seoul, Korea, Republic ofSeverance Hospital
May 30, 2022
Clear Cell Renal Cell Carcinoma Trial in Boston (Abemaciclib, MK-6482)
Recruiting
- Clear Cell Renal Cell Carcinoma
- Abemaciclib
- MK-6482
-
Boston, Massachusetts
- +1 more
Dec 14, 2022
Anatomic Stage IV Breast Cancer AJCC v8, Hormone Receptor Positive Breast Carcinoma, Metastatic Breast Carcinoma Trial in Duarte
Recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +3 more
- Abemaciclib
- Questionnaire Administration
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 1, 2022
Myelofibrosis Due to and Following Polycythemia Vera Trial in United States (Ruxolitinib, Abemaciclib)
Recruiting
- Myelofibrosis Due to and Following Polycythemia Vera
- Ruxolitinib
- Abemaciclib
-
Basking Ridge, New Jersey
- +6 more
Jan 26, 2023
Prostatic Tumors Trial in Germany, Spain, United States (Abemaciclib, Darolutamide, LHRH agonist/antagonist)
Not yet recruiting
- Prostatic Neoplasms
- Abemaciclib
- +2 more
-
Mineola, New York
- +14 more
Aug 23, 2023
Adenocarcinoma of Endometrium Trial in United States (Fulvestrant, Abemaciclib)
Recruiting
- Adenocarcinoma of Endometrium
- Fulvestrant
- Abemaciclib
-
Basking Ridge, New Jersey
- +6 more
Oct 12, 2022
Early-stage Breast Cancer, Diarrhea, Adverse Drug Event Trial in Sweden (SPC-flakes, Salovum, Placebo)
Recruiting
- Early-stage Breast Cancer
- +2 more
- SPC-flakes
- +2 more
-
Eskilstuna, Sweden
- +6 more
Nov 28, 2023
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in San
Recruiting
- Castration-Resistant Prostate Carcinoma
- +6 more
- Abemaciclib
- Lutetium Lu 177-PSMA-617
-
San Francisco, CaliforniaUniversity of California, San Francisco
Sep 8, 2022
Advanced Dedifferentiated Liposarcoma Trial in United States (Abemaciclib, Placebo)
Recruiting
- Advanced Dedifferentiated Liposarcoma
- Abemaciclib
- Placebo
-
Jacksonville, Florida
- +6 more
Jul 27, 2022
Metastatic Malignant Solid Tumor, Metastatic NUT Carcinoma, Unresectable Malignant Solid Tumor Trial (Abemaciclib, BET
Suspended
- Metastatic Malignant Solid Neoplasm
- +3 more
- Abemaciclib
- +3 more
-
Boston, MassachusettsDana-Farber - Harvard Cancer Center LAO
Sep 17, 2022
Metastatic Breast Cancer, Locally Advanced Breast Cancer, Hormone Receptor Positive Tumor Trial in Durham (Abemaciclib,
Recruiting
- Metastatic Breast Cancer
- +2 more
- Abemaciclib
- +2 more
-
Durham, North CarolinaDuke University Medical Center
Jun 7, 2022
HNSCC Trial in Tucson (Abemaciclib)
Recruiting
- HNSCC
- Abemaciclib
-
Tucson, ArizonaUniversity of Arizona
Mar 3, 2022
Breast Cancer Trial in Philadelphia (Abemaciclib, Hydroxychloroquine)
Recruiting
- Breast Cancer
- Abemaciclib
- Hydroxychloroquine
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Dec 13, 2021
Abemaciclib in Combination With Endocrine Therapy as First Line
Recruiting
- Breast Cancer/ Metastatic Breast Cancer
- Abemaciclib
-
Munich, GermanyKlinikum rechts der Isar der TU München, Klinik und Poliklinik f
Apr 26, 2022
Prostate Cancer Trial in Birmingham (Abemaciclib 150 MG by mouth twice daily, Androgen deprivation therapy (ADT), Radiation
Recruiting
- Prostate Cancer
- Abemaciclib 150 MG by mouth twice daily
- +2 more
-
Birmingham, AlabamaUniversity of Alabama at Birmingham (UAB)
Mar 18, 2022
Estrogen-receptor-positive Breast Cancer, HER2/Neu-Negative Breast Cancer, Advanced Breast Cancerv Trial in Chicago
Not yet recruiting
- Estrogen-receptor-positive Breast Cancer
- +3 more
- elacestrant, palbociclib, abemaciclib, ribociclib
-
Chicago, IllinoisNorthwestern University
Sep 25, 2023
Breast Cancer Trial in Athens
Recruiting
- Breast Cancer
-
Athens, GreeceHellenic Oncology Cooperative Group
May 13, 2022
Cancer Metastatic Trial in Pierre Benite, Rennes (Paclitaxel injection, Capecitabine tablets, Letrozole 2.5mg)
Recruiting
- Cancer Metastatic
- Paclitaxel injection
- +5 more
-
Pierre Benite, France
- +1 more
May 11, 2022
Advanced Breast Cancer Trial in Lebanon (Fulvestrant, Neratinib, Alpelisib)
Not yet recruiting
- Advanced Breast Cancer
- Fulvestrant
- +4 more
-
Lebanon, New HampshireDartmouth Hitchcock Medical Center
Jun 28, 2023
The Incidence of AEs and SAEs Receiving Verzenios® Over a Period of Approximately 24 Weeks Trial (Verzenios)
Not yet recruiting
- The Incidence of AEs and SAEs Receiving Verzenios® Over a Period of Approximately 24 Weeks
- Verzenios
- (no location specified)
Mar 3, 2022